Microarrays were developed and commercialized in the eighties. Since then, market has offered tremendous growth and hence has seen an influx of players vying fiercely for a share or this market. The Global DNA & Gene Chip (microarray) market was valued at $760 million in 2010 and is expected to reach $1,425.2 million by 2015 growing at a CAGR of and 13.4%. The oDNA segment accounted for the largest share – 98% – of the global DNA & gene chip market in 2010.

Gene Expression currently forms the largest application market as gene expression products are used in a wide variety of research activities including life sciences research, clinical diagnostics, biodefense, and agriculture. While this application contributed 28% to the Global DNA & Gene Chip (microarray) market revenues in 2010, cancer diagnosis and treatment application is expected to dominate the applications market by 2015; accounting for about 24% share in the market.

This research report categorizes the Global DNA & Gene Chip (microarray) market on the basis of applications, types, and geography; forecasting revenues and analyzing trends in each of the following submarkets:

On the basis of applications

Gene Expression, Cancer Diagnostics & Treatments, Drug Discovery, Genetics (DNA sequencing by hybridization, reverse genetics, functional genomics and genomic mismatch scanning, gene mapping, diagnosis), SNP Analysis, Screening & Monitoring of patient data during clinical trials, Proteomics, Toxicogenomics, Microbial Genotyping, Agricultural Biology, and Environmental Control

On the basis of types

• Oligonucleotide DNA Microarrays (oDNA) and Complementary DNA Microarrays (cDNA)
• On the basis of geography
• North America, Europe, Asia, and Rest of the World.

Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide market tables for covering the sub-segments. In addition, the report also provides more than 30 company profiles covering all the sub-segments.

Key questions answered

• Which are the high-growth segments/cash cows and how is the market segmented in terms of applications and materials?
• What are market estimates and forecasts; which markets are doing well and which are not?
• Where are the gaps and opportunities; what is driving the market?
• Which are the key playing fields? Which are the winning edge imperatives?
• How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?
• Powerful Research and analysis

TABLE OF CONTENTS

EXECUTIVE SUMMARY    
    OBJECTIVE    
    MARKET SCENARIO    
        
1    INTRODUCTION    
1.1    KEY TAKE-AWAYS    
1.2    REPORT DESCRIPTION    
1.3    MARKETS COVERED    
1.4    STAKEHOLDERS    
1.5    RESEARCH METHODOLOGY    

2    SUMMARY    

3    MARKET OVERVIEW    
3.1    INTRODUCTION    
3.2    DNA MICROARRAY REQUIREMENTS    
3.2.1    FIRM TETHERING    
3.2.2    UNHINDERED BINDING    
3.2.3    USING LARGER & DNA MOLECULES    
3.2.4    NO CROSS CONTAMINATION    
3.3    DNA MICROARRAY DEVELOPMENT TRENDS    
3.3.1    GLASS ARRAYS TRENDS    
3.3.2    AMERSHAM'S COATING TECHNOLOGY    
3.3.3    AGILENT TECHNOLOGY    
3.3.4    PROBE TECHNOLOGY    
3.4    COMPARISON OF INKJET & PHOTOLITHOGRAPHIC TECHNOLOGY    
3.4.1    PHOTOLITHOGRAPHY    
3.4.2    INKJET TECHNOLOGY    
3.5    KEY CHALLENGES IN DNA/GENE MICROARRAY MANUFACTURING    
3.5.1    BASE PAIR MISMATCH    
3.5.2    POOR BINDING    
3.5.3    HYBRIDIZATION    
3.5.4    VARIABLE SIGNAL STRENGTHS    
3.5.5    INTERPRETATION OF MICROARRAYS    
3.5.6    INTRAMICROARRAY VARIABILITY & INTERMICROARRAY VARIABILITY    
3.5.7    THE INCOMPLETE REACTION PROBLEM    
3.5.8    PROBE DESIGN    
3.5.9    SUBSTRATES    
3.5.10    MARKER MOLECULES    
3.5.11    UNREACTIVE SURFACE    
3.6    MARKET DRIVERS    
3.6.1    LARGE SCALE DNA/GENE CHIP INITIATIVES    
3.6.2    GROWTH OF PERSONALIZED MEDICINE    
3.6.3    NEED FOR EARLY CANCER DETECTION & CANCER DIAGNOSIS    
3.6.4    DNA/GENE CHIPS MINIATURIZATION    
3.6.5    GOVERNMENT FUNDING BOOSTS MARKET GROWTH    
3.7    RESTRAINTS    
3.7.1    KNOWLEDGE CONSTRAINTS WITH RESPECT TO TECHNICAL KNOW-HOW & SKILLED EMPLOYEES        
3.7.2    ALTERNATE TECHNOLOGIES    
3.8    OPPORTUNITIES    
3.8.1    ECONOMIES OF ASIA PROVIDE SIGNIFICANT GROWTH OPPORTUNITIES TO THE DNA MICROARRAY MARKET        
3.9    BURNING ISSUES    
3.9.1    PATENT DISPUTES    
3.10    MARKET TRENDS    
3.10.1    RELOCATING MANUFACTURING FACILITIES TO GAIN COMPETITIVE EDGE    
3.10.1.1    Advantage Singapore    
3.10.2    WINNING IMPERATIVES    
3.10.2.1    Standardization    
3.10.2.2    Size    
3.10.2.3    Cost    
3.10.2.4    Compatibility    
3.10.2.5    End-to-end solutions    
3.11    PATENT ANALYSIS    
3.12    END-USER ANALYSIS    
3.13    MARKET SHARE FOR MAJOR PLAYERS    

4    DNA/GENE CHIPS (DNA MICROARRAY) MARKET BY TYPES & APPLICATIONS    
4.1    INTRODUCTION    
4.2    MARKET SEGMENTATION    
4.3    DNA/GENE CHIPS (DNA MICROARRAY) MARKET BY TYPES    
4.3.1    OLIGONUCLEOTIDE BASED CHIPS    
4.3.1.1    Photolithographic (light generated) oligonucleotide chips    
4.3.1.2    Inkjet print technology generated oligonucleotide chips    
4.3.2    CDNA CHIPS    
4.3.2.1    Mechanical microspotting generated cDNA chips    
4.3.2.2    Inkjet print technology generated cDNA chips    
4.4    DNA/GENE CHIPS (DNA MICROARRAY) MARKET BY APPLICATIONS    
4.4.1    GENE EXPRESSION    
4.4.2    SNP ANALYSIS    
4.4.3    CANCER DIAGNOSIS & TREATMENT    
4.4.4    GENOMICS    
4.4.4.1    DNA sequencing in hybridization    
4.4.4.2    Functional genomics & genomic mis-match scanning    
4.4.4.3    Reverse genetics    
4.4.4.4    Diagnosis & genetic mapping    
4.4.5    PROTEOMICS    
4.4.6    AGRICULTURAL BIOLOGY    
4.4.7    ENVIRONMENTAL CONTROL    
4.4.8    TOXICOGENOMICS    
4.4.9    DRUG DISCOVERY    
4.4.10    SCREENING & MONITORING OF PATIENT DATA IN CLINICAL TRIALS    
4.4.11    MICROBIAL GENOTYPING    

5    GEOGRAPHIC ANALYSIS    
5.1    INTRODUCTION    
5.2    NORTH AMERICA    
5.2.1    U.S.    
5.2.2    CANADA    
5.3    EUROPE    
5.3.1    GERMANY    
5.3.2    FRANCE    
5.3.3    ITALY    
5.3.4    SPAIN    
5.3.5    UNITED KINGDOM    
5.4    ASIA    
5.4.1    INDIA    
5.4.2    CHINA    
5.4.3    JAPAN    
5.4.4    SOUTH KOREA    
5.5    REST OF THE WORLD (ROW)    

6    COMPETITIVE ANALYSIS    
6.1    KEY STRATEGIES    

7    COMPANY PROFILES    
7.1    AFFYMETRIX INC    
7.1.1    OVERVIEW    
7.1.2    FINANCIALS    
7.1.3    PRODUCTS & SERVICES    
7.1.4    STRATEGY    
7.1.5    DEVELOPMENTS    
7.2    AGILENT TECHNOLOGIES INC    
7.2.1    OVERVIEW    
7.2.2    FINANCIALS    
7.2.3    PRODUCTS & SERVICES    
7.2.4    STRATEGY    
7.2.5    DEVELOPMENTS    
7.3    BIOMÉRIEUX SA    
7.3.1    OVERVIEW    
7.3.2    FINANCIALS    
7.3.3    PRODUCTS & SERVICES    
7.3.4    STRATEGY    
7.3.5    DEVELOPMENTS    
7.4    BIOMETRIX TECHNOLOGY INC    
7.4.1    OVERVIEW    
7.4.2    PRODUCTS & SERVICES    
7.4.3    STRATEGY    
7.5    BIONEER CORP    
7.5.1    OVERVIEW    
7.5.2    FINANCIALS    
7.5.3    PRODUCTS & SERVICES    
7.5.4    STRATEGY    
7.5.5    DEVELOPMENTS    
7.6    CAPITALBIO CORP    
7.6.1    OVERVIEW    
7.6.2    PRODUCTS & SERVICES    
7.6.3    STRATEGY    
7.6.4    DEVELOPMENTS    
7.7    EUROFINS MWG OPERON    
7.7.1    OVERVIEW    
7.7.2    PRODUCTS & SERVICES    
7.7.3    STRATEGY    
7.7.4    DEVELOPMENTS    
7.8    GREINER BIO-ONE    
7.8.1    OVERVIEW    
7.8.2    PRODUCT & SERVICES    
7.8.3    STRATEGY    
7.8.4    DEVELOPMENTS    
7.9    ILLUMINA INC    
7.9.1    OVERVIEW    
7.9.2    FINANCIALS    
7.9.3    PRODUCTS & SERVICES    
7.9.4    STRATEGY    
7.9.5    DEVELOPMENTS    
7.10    LC SCIENCES    
7.10.1    OVERVIEW    
7.10.2    PRODUCTS & SERVICES    
7.10.3    STRATEGY    
7.10.4    DEVELOPMENTS    
7.11    LIFEGEN TECHNOLOGIES    
7.11.1    OVERVIEW    
7.11.2    PRODUCTS & SERVICES    
7.11.3    STRATEGY    
7.11.4    DEVELOPMENTS    
7.12    LIFE TECHNOLOGIES CORP    
7.12.1    OVERVIEW    
7.12.2    FINANCIALS    
7.12.3    PRODUCTS & SERVICES    
7.12.4    STRATEGY    
7.12.5    DEVELOPMENTS    
7.13    MACROGEN INC    
7.13.1    OVERVIEW    
7.13.2    PRODUCTS & SERVICES    
7.13.3    STRATEGY    
7.13.4    DEVELOPMENTS            
7.14    MICROARRAYS INC    
7.14.1    OVERVIEW    
7.14.2    PRODUCTS & SERVICES    
7.14.3    STRATEGY    
7.14.4    DEVELOPMENTS    
7.15    NGK INSULATORS LTD    
7.15.1    OVERVIEW    
7.15.2    FINANCIALS    
7.15.3    PRODUCTS & SERVICES    
7.15.4    STRATEGY    
7.15.5    DEVELOPMENTS    
7.16    OCIMUM BIOSOLUTIONS LTD    
7.16.1    OVERVIEW    
7.16.2    PRODUCTS & SERVICES    
7.16.3    STRATEGY    
7.16.4    DEVELOPMENTS    
7.17    OXFORD GENE TECHNOLOGY    
7.17.1    OVERVIEW    
7.17.2    PRODUCTS & SERVICES    
7.17.3    STRATEGY    
7.17.4    DEVELOPMENTS    
7.18    PERKINELMER    
7.18.1    OVERVIEW    
7.18.2    FINANCIALS    
7.18.3    PRODUCTS & SERVICES    
7.18.4    STRATEGY    
7.18.5    DEVELOPMENTS    
7.19    PAMGENE INTERNATIONAL B.V.    
7.19.1    OVERVIEW    
7.19.2    PRODUCT & SERVICES    
7.19.3    STRATEGY    
7.20    ROCHE NIMBLEGEN INC    
7.20.1    OVERVIEW    
7.20.2    PRODUCTS & SERVICES    
7.20.3    STRATEGY    
7.20.4    DEVELOPMENTS    
7.21    SAVYON DIAGNOSTICS LTD    
7.21.1    OVERVIEW    
7.21.2    PRODUCTS & SERVICES    
7.21.3    STRATEGY    
7.21.4    DEVELOPMENTS    
7.22    SEQUENOM INC    
7.22.1    OVERVIEW    
7.22.2    FINANCIALS    
7.22.3    PRODUCTS & SERVICES    
7.22.4    STRATEGY    
7.22.5    DEVELOPMENTS    
7.23    SHANGHAI BIOCHIP CO LTD    
7.23.1    OVERVIEW    
7.23.2    PRODUCTS & SERVICES    
7.23.3    STRATEGY    
7.23.4    DEVELOPMENTS    
7.24    SIGMA-ALDRICH    
7.24.1    OVERVIEW    
7.24.2    FINANCIALS    
7.24.3    PRODUCTS & SERVICES    
7.24.4    STRATEGY    
7.24.5    DEVELOPMENTS    
7.25    SURMODICS INC    
7.25.1    OVERVIEW    
7.25.2    FINANCIALS    
7.25.3    PRODUCT & SERVICES    
7.25.4    STRATEGY    
7.25.5    DEVELOPMENTS    
7.26    SCIENION AG    
7.26.1    OVERVIEW    
7.26.2    PRODUCTS & SERVICES    
7.26.3    STRATEGY    
7.26.4    DEVELOPMENTS    
7.27    TOSHIBA CORP    
7.27.1    OVERVIEW    
7.27.2    FINANCIALS    
7.27.3    PRODUCTS & SERVICES    
7.28    WAFERGEN BIOSYSTEMS INC    
7.28.1    OVERVIEW    
7.28.2    FINANCIALS    
7.28.3    PRODUCTS & SERVICES    
7.28.4    STRATEGY    
7.28.5    DEVELOPMENTS    
7.29    ARRAYIT CORP    
7.29.1    OVERVIEW    
7.29.2    FINANCIALS    
7.29.3    PRODUCTS & SERVICES    
7.29.4    STRATEGY    
7.29.5    DEVELOPMENTS    
7.30    OTHERS    
7.30.1    APPLIED MICROARRAYS INC    
7.30.1.1    Overview    
7.30.1.2    Products & Services    
7.30.2    CANON INC    
7.30.2.1    Overview    
7.30.2.2    Financials    
7.30.2.3    Products & Services    
7.30.3    GENISPHERE LLC    
7.30.3.1    Overview    
7.30.3.2    Products & Services    
7.30.4    HITACHI LTD    
7.30.4.1    Overview    
7.30.4.2    Financials    
7.30.4.3    Products & Services             
7.30.5    CYTOPATHFINDER INC    
7.30.5.1    Overview    
7.30.5.2    Products & Services    
7.30.6    INTEGRATED DNA TECHNOLOGIES    
7.30.6.1    Overview    
7.30.6.2    Products & Services    
7.30.7    EXIQON    
7.30.7.1    Overview    
7.30.7.2    Financials    
7.30.7.3    Products & Services    
7.30.8    SAMSUNG ELECTRONICS CO LTD    
7.30.8.1    Overview    
7.30.8.2    Financials    
7.30.8.3    Products & Services    
7.30.9    PROMEGA CORP    
7.30.9.1    Overview    
7.30.9.2    Products & Services    
7.30.10    THERMO FISHER SCIENTIFIC INC    
7.30.10.1    Overview    
7.30.10.2    Financials    
7.30.10.3    Products & Services    
    
APPENDIX    
    U.S. PATENTS    
    EUROPE PATENTS
    JAPAN PATENTS    
    WIPO PATENTS   

LIST OF TABLES
    
TABLE 1    GLOBAL DNA & GENE CHIP MARKET REVENUE, BY TYPES, 2008 – 2015 ($MILLION)
TABLE 2    GLOBAL DNA & GENE CHIP MARKET, BY TYPES, 2008 – 2015 (UNIT SHIPMENTS)        
TABLE 3    TOP 5 DNA MICROARRAY TECHNOLOGIES    
TABLE 4    COMPARISON BETWEEN PHOTOLITHOGRAPHY &  INKJET TECHNOLOGY    
TABLE 5    PATENT DISPUTES IN DNA MICROARRAY MARKET    
TABLE 6    TAX ENVIRONMENT    
TABLE 7    TAX ENVIRONMENT: FOR NEW START UP COMPANIES IN SINGAPORE    
TABLE 8    ODNA CHIP MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 9    ODNA CHIP MARKET, BY GEOGRAPHY, 2008 – 2015 (UNIT SHIPMENTS)    
TABLE 10    CDNA CHIP MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($THOUSAND)    
TABLE 11    CDNA CHIP MARKET, BY GEOGRAPHY, 2008 – 2015 (UNIT SHIPMENTS)    
TABLE 12    GLOBAL DNA & GENE CHIP MARKET REVENUE, BY APPLICATIONS, 2008 – 2015 ($MILLION)        
TABLE 13    GLOBAL DNA & GENE CHIP MARKET, BY APPLICATIONS, 2008 – 2015 (UNIT SHIPMENTS)        
TABLE 14    GENE EXPRESSION PRODUCT PORTFOLIO    
TABLE 15    GENE EXPRESSION MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015     ($MILLION)        
TABLE 16    GENE EXPRESSION MARKET, BY GEOGRAPHY, 2008 – 2015 (UNIT SHIPMENTS)        
TABLE 17    SNP ANALYSIS PRODUCT PORTFOLIO    
TABLE 18    SNP ANALYSIS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)            
TABLE 19    SNP ANALYSIS MARKET, BY GEOGRAPHY, 2008 – 2015 (UNIT SHIPMENTS)        
TABLE 20    CANCER DIAGNOSTICS & TREATMENT MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)        
TABLE 21    CANCER DIAGNOSTICS & TREATMENT MARKET, BY GEOGRAPHY, 2008 – 2015 (UNIT SHIPMENTS)        
TABLE 22    CANCER DIAGNOSIS & TREATMENT PRODUCT PORTFOLIO    
TABLE 23    GENOMICS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 24    GENOMICS MARKET, BY GEOGRAPHY, 2008 – 2015 (UNIT SHIPMENTS)    
TABLE 25    DIAGNOSIS & GENETIC MAPPING PRODUCT PORTFOLIO    
TABLE 26    PROTEOMICS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 27    PROTEOMICS MARKET, BY GEOGRAPHY, 2008 – 2015 (UNIT SHIPMENTS)        
TABLE 28    AGRICULTURAL BIOLOGY PRODUCT PORTFOLIO    
TABLE 29    AGRICULTURAL BIOLOGY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)        
TABLE 30    AGRICULTURAL BIOLOGY MARKET, BY GEOGRAPHY, 2008 – 2015 (UNIT SHIPMENTS)        
TABLE 31    ENVIRONMENTAL CONTROL MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($THOUSAND)        
TABLE 32    ENVIRONMENTAL CONTROL MARKET, BY GEOGRAPHY, 2008 – 2015 (UNIT SHIPMENTS)        
TABLE 33    TOXICOGENOMICS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)            
TABLE 34    TOXICOGENOMICS MARKET, BY GEOGRAPHY, 2008 – 2015 (UNIT SHIPMENTS)        
TABLE 35    DRUG DISCOVERY MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)
TABLE 36    GLOBAL DRUG DISCOVERY MARKET, BY GEOGRAPHY, 2008 – 2015 (UNIT SHIPMENTS)        
TABLE 37    SCREENING & MONITORING PATIENT DATA IN CLINICAL TRIALS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)        
TABLE 38    SCREENING & MONITORING PATIENT DATA IN CLINICAL TRIALS MARKET, BY GEOGRAPHY, 2008 – 2015 (UNIT SHIPMENTS)        
TABLE 39    MICROBIAL GENOTYPING MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)        
TABLE 40    MICROBIAL GENOTYPING MARKET, BY GEOGRAPHY, 2008 – 2015 (UNIT SHIPMENTS)        
TABLE 41    NORTH AMERICA: DNA & GENE CHIP MARKET, BY REVENUE,    BY GEOGRAPHY, 2008 – 2015 ($MILLION)        
TABLE 42    NORTH AMERICA: DNA & GENE CHIP MARKET, BY GEOGRAPHY, 2008 – 2015 (UNIT SHIPMENTS)        
TABLE 43    NORTH AMERICA: DNA & GENE CHIP MARKET, BY REVENUE,    BY APPLICATIONS, 2008 – 2015 ($MILLION)        
TABLE 44    NORTH AMERICA: DNA & GENE CHIP MARKET, BY APPLICATIONS, 2008 – 2015 (UNIT SHIPMENTS)        
TABLE 45    U.S.: DNA & GENE CHIP MARKET, BY REVENUE, BY TYPES, 2008 – 2015 ($MILLION)        
TABLE 46    U.S.: DNA & GENE CHIP MARKET, BY TYPES, 2008 – 2015 (UNIT SHIPMENTS)        
TABLE 47    U.S.: DNA & GENE CHIP MARKET, BY REVENUE, BY APPLICATIONS, 2008 – 2015 ($MILLION)        
TABLE 48    U.S.: DNA & GENE CHIP MARKET, BY APPLICATIONS, 2008 – 2015 (UNIT SHIPMENTS)        
TABLE 49    CANADA: DNA & GENE CHIP MARKET , BY REVENUE, BY TYPES, 2008 – 2015 ($THOUSAND)        
TABLE 50    CANADA: DNA & GENE CHIP MARKET, BY TYPES, 2008 – 2015    (UNIT SHIPMENTS)        
TABLE 51    CANADA: DNA & GENE CHIP MARKET, BY REVENUE, BY APPLICATIONS, 2008 –     2015 ($THOUSAND)        
TABLE 52    CANADA: DNA & GENE CHIP MARKET, BY APPLICATIONS, 2008 – 2015 (UNIT SHIPMENTS)        
TABLE 53    EUROPE: DNA & GENE CHIP MARKET REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 54    EUROPE: DNA & GENE CHIP MARKET, BY GEOGRAPHY, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 55    EUROPE: DNA & GENE CHIP MARKET, BY REVENUE, BY APPLICATIONS, 2008 –     2015 ($MILLION)        
TABLE 56    EUROPE: DNA & GENE CHIP MARKET, BY APPLICATIONS, 2008 – 2015 (UNIT SHIPMENTS)        
TABLE 57    GERMANY: DNA & GENE CHIP MARKET, BY REVENUE, BY TYPES, 2008 – 2015 ($THOUSAND)    
TABLE 58    GERMANY: DNA & GENE CHIP MARKET, BY TYPES, 2008 – 2015 (UNIT SHIPMENTS)    
TABLE 59    GERMANY: DNA & GENE CHIP MARKET, BY REVENUE, BY APPLICATIONS, 2008 – 2015 ($THOUSAND)    
TABLE 60    GERMANY: DNA & GENE CHIP MARKET, BY APPLICATIONS, 2008 – 2015 (UNIT SHIPMENTS)    
TABLE 61    FRANCE: DNA & GENE CHIP MARKET, BY REVENUE, BY TYPES, 2008 – 2015 ($THOUSAND)    
TABLE 62    FRANCE: DNA & GENE CHIP MARKET, BY TYPES, 2008 – 2015    (UNIT SHIPMENTS)    
TABLE 63    FRANCE: DNA & GENE CHIP MARKET, BY REVENUE, BY APPLICATIONS, 2008 – 2015 ($THOUSAND)    
TABLE 64    FRANCE: DNA & GENE CHIP MARKET, BY APPLICATIONS, 2008 – 2015 (UNIT SHIPMENTS)    
TABLE 65    ITALY: DNA & GENE CHIP MARKET , BY REVENUE, BY TYPES,     2008 – 2015 ($THOUSAND)    
TABLE 66    ITALY: DNA & GENE CHIP MARKET, BY TYPES, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 67    ITALY: DNA & GENE CHIP MARKET, BY REVENUE, BY APPLICATIONS, 2008 – 2015 ($THOUSAND)
TABLE 68    ITALY: DNA & GENE CHIP MARKET, BY APPLICATIONS, 2008 – 2015 (UNIT SHIPMENTS)    
TABLE 69    SPAIN: DNA & GENE CHIP MARKET, BY REVENUE, BY TYPES,     2008 – 2015 ($THOUSAND)        
TABLE 70    SPAIN: DNA & GENE CHIP MARKET, BY TYPES, 2008 – 2015 (UNIT SHIPMENTS)        
TABLE 71    SPAIN: DNA & GENE CHIP MARKET, BY REVENUE, BY APPLICATIONS, 2008 – 2015 ($THOUSAND)    
TABLE 72    SPAIN: DNA & GENE CHIP MARKET, BY APPLICATIONS, 2008 – 2015 (UNIT SHIPMENTS)    
TABLE 73    UK: DNA & GENE CHIP MARKET , BY REVENUE, BY TYPES, 2008 – 2015  ($THOUSAND)    
TABLE 74    UK: DNA & GENE CHIP MARKET, BY TYPES, 2008 – 2015 (UNIT SHIPMENTS)    
TABLE 75    UK: DNA & GENE CHIP MARKET, BY REVENUE, BY APPLICATIONS, 2008 – 2015 ($THOUSAND)    
TABLE 76    UK: DNA & GENE CHIP MARKET, BY APPLICATIONS, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 77    ASIA: DNA & GENE CHIP MARKET, BY REVENUE, BY GEOGRAPHY, 2008 – 2015 ($MILLION)    
TABLE 78    ASIA: DNA & GENE CHIP MARKET, BY GEOGRAPHY, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 79    ASIA: DNA & GENE CHIP MARKET, BY REVENUE, BY APPLICATIONS, 2008 – 2015 ($MILLION)    
TABLE 80    ASIA: DNA & GENE CHIP MARKET, BY APPLICATIONS, 2008 – 2015 (UNIT SHIPMENTS)    
TABLE 81    INDIA: DNA & GENE CHIP MARKET, BY REVENUE, BY TYPES,    2008 – 2015 ($THOUSAND)    
TABLE 82    INDIA: DNA & GENE CHIP MARKET, BY TYPES, 2008 – 2015 (UNIT SHIPMENTS)    
TABLE 83    INDIA: DNA & GENE CHIP MARKET, BY REVENUE,  BY APPLICATIONS, 2008 – 2015 ($THOUSAND)
TABLE 84    INDIA: DNA & GENE CHIP MARKET, BY APPLICATIONS, 2008 – 2015 (UNIT SHIPMENTS)    
TABLE 85    CHINA: DNA & GENE CHIP MARKET, BY REVENUE, BY TYPES,     2008 – 2015 ($THOUSAND)        
TABLE 86    CHINA: DNA & GENE CHIP MARKET, BY TYPES, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 87    CHINA: DNA & GENE CHIP MARKET, BY REVENUE, BY APPLICATIONS, 2008 – 2015 ($THOUSAND)
TABLE 88    CHINA: DNA & GENE CHIP MARKET, BY APPLICATIONS, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 89    JAPAN: DNA & GENE CHIP MARKET, BY REVENUE, BY TYPES, 2008 – 2015 ($THOUSAND)    
TABLE 90    JAPAN: DNA & GENE CHIP MARKET, BY TYPES, 2008 – 2015 (UNIT SHIPMENTS)    
TABLE 91    JAPAN: DNA & GENE CHIP MARKET, BY REVENUE, BY APPLICATIONS, 2008 – 2015 ($THOUSAND)    
TABLE 92    JAPAN: DNA & GENE CHIP MARKET, BY APPLICATIONS, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 93    SOUTH KOREA: DNA & GENE CHIP MARKET, BY REVENUE, BY TYPES, 2008 – 2015 ($THOUSAND)    
TABLE 94    SOUTH KOREA: DNA & GENE CHIP MARKET, BY TYPES, 2008 – 2015 (UNIT SHIPMENTS)    
TABLE 95    SOUTH KOREA: DNA & GENE CHIP MARKET, BY REVENUE, BY APPLICATIONS, 2008 – 2015 ($THOUSAND)    
TABLE 96    SOUTH KOREA: DNA & GENE CHIP MARKET, BY APPLICATIONS, 2008 – 2015 (UNIT SHIPMENTS)    
TABLE 97    ROW: DNA & GENE CHIP MARKET, BY REVENUE, BY TYPES,     2008 – 2015 ($THOUSAND)    
TABLE 98    ROW: DNA & GENE CHIP MARKET, BY TYPES, 2008 – 2015 (UNIT SHIPMENTS)
TABLE 99    ROW: DNA & GENE CHIP MARKET, BY REVENUE, BY APPLICATIONS, 2008 – 2015 ($THOUSAND)
TABLE 100    ROW: DNA & GENE CHIP MARKET, BY APPLICATIONS, 2008 – 2015 (UNIT SHIPMENTS)    
TABLE 101    NEW PRODUCT LAUNCHES    
TABLE 102    MERGERS & ACQUISITIONS    
TABLE 103    AGREEMENTS & COLLABORATIONS    
TABLE 104    PARTNERSHIPS    
TABLE 105    APPROVALS    
TABLE 106    EXPANSIONS    
TABLE 107    AFFYMETRIX INC: TOTAL REVENUES & R&D EXPENSES ($MILLION)    
TABLE 108    AFFYMETRIX INC: TOTAL REVENUES, BY GEOGRAPHY ($MILLION)    
TABLE 109    AFFYMETRIX INC: TOTAL REVENUES, BY SEGMENTS ($MILLION)    
TABLE 110    AGILENT TECHNOLOGIES: TOTAL REVENUES & R&D EXPENSES ($MILLION)        
TABLE 111    AGILENT TECHNOLOGIES: TOTAL REVENUES, BY GEOGRAPHY ($MILLION)    
TABLE 112    AGILENT TECHNOLOGIES: TOTAL REVENUES, BY SEGMENTS ($MILLION)        
TABLE 113    BIOMÉRIEUX SA: TOTAL REVENUES & R&D EXPENSES ($MILLION)    
TABLE 114    BIONEER CORP: TOTAL REVENUES & R&D EXPENSES ($MILLION)    
TABLE 115    BIONEER CORP: TOTAL REVENUES, BY SEGMENTS ($MILLION)    
TABLE 116    ILLUMINA INC: TOTAL REVENUES & R&D EXPENSE FOR FISCAL YEAR ENDED ($THOUSAND)    
TABLE 117    ILLUMINA INC: TOTAL REVENUES, BY GEOGRAPHY ($THOUSAND)    
TABLE 118    ILLUMINA INC: TOTAL REVENUES, BY SEGMENTS ($THOUSAND)    
TABLE 119    LIFE TECHNOLOGIES CORP: TOTAL REVENUES & R&D EXPENSES ($MILLION)
TABLE 120    LIFE TECHNOLOGIES CORP: TOTAL REVENUES, BY GEOGRAPHY ($THOUSAND)        
TABLE 121    LIFE TECHNOLOGIES CORP: TOTAL REVENUES, BY SEGMENTS ($MILLION)    
TABLE 122    NGK INSULATORS LTD: TOTAL REVENUES & R&D EXPENSES ($THOUSAND)    
TABLE 123    NGK INSULATORS LTD: TOTAL REVENUES, BY GEOGRAPHY ($MILLION)    
TABLE 124    NGK INSULATORS LTD: TOTAL REVENUES, BY SEGMENTS ($MILLION)    
TABLE 125    PERKINELMER: TOTAL REVENUES & R&D EXPENSES ($MILLION)    
TABLE 126    PERKINELMER: TOTAL REVENUES, BY GEOGRAPHY ($MILLION)    
TABLE 127    PERKINELMER: TOTAL REVENUES, BY SEGMENTS ($MILLION)    
TABLE 128    SEQUENOM INC: TOTAL REVENUES & R&D EXPENSES ($THOUSAND)    
TABLE 129    SEQUENOM INC: TOTAL REVENUES, BY GEOGRAPHY ($MILLION)    
TABLE 130    SEQUENOM INC: TOTAL REVENUES, BY SEGMENTS ($MILLION)    
TABLE 131    SIGMA-ALDRICH: TOTAL REVENUES & R&D EXPENSES ($MILLION)    
TABLE 132    SIGMA-ALDRICH: TOTAL REVENUES, BY GEOGRAPHY  ($MILLION)    
TABLE 133    SURMODICS INC: TOTAL REVENUE ($THOUSAND)    
TABLE 134    TOSHIBA CORP: TOTAL REVENUES & R&D EXPENSES ($BILLION)    
TABLE 135    TOSHIBA CORP: TOTAL REVENUES, BY GEOGRAPHY ($BILLION)    
TABLE 136    TOSHIBA CORP: TOTAL REVENUES, BY SEGMENTS ($BILLION)    
TABLE 137    WAFERGEN BIOSYSTEMS: TOTAL REVENUES & R&D EXPENSES ($THOUSAND)        
TABLE 138    ARRAYIT CORP: TOTAL REVENUES & R&D EXPENSES ($THOUSAND)    
TABLE 139    ARRAYIT CORP: TOTAL REVENUES, BY SEGMENTS ($THOUSAND)    
TABLE 140    CANON INC: TOTAL REVENUES & R&D EXPENSES ($MILLION)    
TABLE 141    CANON INC: TOTAL REVENUES, BY GEOGRAPHY ($MILLION)    
TABLE 142    CANON INC: TOTAL REVENUES, BY SEGMENTS ($MILLION)    
TABLE 143    HITACHI LTD: TOTAL REVENUES & R&D EXPENSES ($MILLION)    
TABLE 144    HITACHI LTD: TOTAL REVENUES, BY GEOGRAPHY ($MILLION)    
TABLE 145    HITACHI LTD: TOTAL REVENUES, BY SEGMENTS ($MILLION)    
TABLE 146    EXIQON: TOTAL REVENUES & R&D EXPENSES ($THOUSAND)    
TABLE 147    EXIQON: TOTAL REVENUES, BY GEOGRAPHY ($THOUSAND)    
TABLE 148    EXIQON A/S: TOTAL REVENUES, BY SEGMENTS ($THOUSAND)    
TABLE 149    SAMSUNG ELECTRONICS CO LTD: TOTAL REVENUES & R&D EXPENSES  $MILLION)    
TABLE 150    SAMSUNG ELECTRONICS CO LTD: TOTAL REVENUES, BY GEOGRAPHY ($MILLION)
TABLE 151    SAMSUNG ELECTRONICS CO LTD: TOTAL REVENUES, BY SEGMENTS     ($MILLION)    
TABLE 152    THERMO FISHER SCIENTIFIC INC: TOTAL REVENUES & R&D EXPENSES ($MILLION)
TABLE 153    THERMO FISHER SCIENTIFIC INC: TOTAL REVENUES, BY GEOGRAPHY     ($MILLION)    
TABLE 154    THERMO FISHER SCIENTIFIC INC: TOTAL REVENUES, BY SEGMENTS ($MILLION)   
 
LIST OF FIGURES

FIGURE 1    GLOBAL DNA & GENE CHIP MARKET 2010 ($MILLION)
FIGURE 2    DNA MICROARRAY MILESTONES
FIGURE 3    MICROFLUIDICS CHIP
FIGURE 4    PATENT ANALYSIS BY ASSIGNEE
FIGURE 5    COMPOSITION OF END-USER (2010 & 2015)
FIGURE 6    MARKET SHARE ANALYSIS (2009)
FIGURE 7    DNA MICROARRAY MARKET SEGMENTATION
FIGURE 8    ODNA MICROARRAY
FIGURE 9    CDNA MICROARRAY
FIGURE 10    MAJOR GROWTH STRATEGIES IN DNA & GENE CHIP MARKET (JANUARY 2008 – MARCH 2011)